Alterity Therapeutics Limited

ATHE | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.91

+$0.13 (+3.44%)

Sep 22, 2026, 2:15 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $64.04M

Enterprise Value $57.64M

Beta -0.03

Average Volume 37.5K

Shares Outstanding (Diluted) 18.13M

Shares Change YoY 72.4%

Institutional Ownership 1.89%

Exchange NASDAQ

ISIN US02155X2053

Price Performance

Price Change 1M -16.8%

Price Change 3M -22.0%

Price Change 6M 13.5%

Price Change YTD 22.5%

Price Change 1Y -12.6%

Price Change 3Y 46.0%

Price Change 5Y -69.8%

1M CAGR (ann.) -15.1%

1Y CAGR (ann.) -13.7%

5Y CAGR (ann.) -22.1%

All-Time CAGR -17.6%

Valuation

PE Ratio -4.32

Forward PE N/A

PEG Ratio 0.22

Forward PEG -0.13

PS Ratio N/A

Forward PS 60.30

PB Ratio 2.22

P/FCF Ratio N/A

P/Adj. FCF Ratio N/A

P/OCF Ratio -0.09

EV/Sales N/A

EV/EBIT -2.03

EV/EBITDA -2.04

EV/FCF N/A

Earnings Yield -24.2%

FCF Yield 0.0%

Adj. FCF Yield 0.0%

Financial Health

Net Cash A$37.26M

Total Debt A$193.48K

Cash & Short-Term Investments A$37.32M

Total Assets A$46.02M

Current Ratio 14.52

Quick Ratio 14.52

Debt / Equity Ratio 0.00

Debt / EBITDA -0.01

Debt / FCF N/A

OCF / Debt -120.02

Interest Coverage 0.00

Altman Z-Score 8.46

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets -50.9%

Return on Equity -48.3%

Return on Invested Capital -57.6%

Return on Capital Employed -66.3%

Return on Tangible Assets -50.9%

Historical Growth (CAGR)

Revenue CAGR 3Y -84.1%

Revenue CAGR 5Y -9.1%

Revenue CAGR 10Y 4.7%

EPS CAGR 3Y 38.4%

EPS CAGR 5Y 43.4%

EPS CAGR 10Y 26.3%

FCF CAGR 3Y 61.5%

FCF CAGR 5Y 12.0%

FCF CAGR 10Y 2.1%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 8

EPS Growth Next 3Y 22.2%

Revenue Growth Next 3Y N/A

Earnings Date Mar 3, 2027

EPS Estimate (next Q) -$0.02

EPS Growth Est (next Q) -93.1%

Revenue Est (next Q) $568.37K

Revenue Growth Est (next Q) 24.0%

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $8

Price Target Upside 106.7%

Cash Flow

Operating Cash Flow A$-23.22M

Free Cash Flow A$0

Adj. Free Cash Flow A$0

FCF Per Share $0

OCF Per Share -$62.13

OCF/S Ratio 0.0%

Income Statement

Revenue A$0

Gross Profit A$-115.29K

Operating Income A$-28.4M

EBITDA A$-28.28M

Net Income A$-23.42M

EPS (Diluted) -$1.32

Revenue / Employee N/A

Profit / Employee $-2.13M

Employees 11